SCHEMBL439662

SCHEMBL439662

C[C@](O)(c1nncc2cc(-c3cccc(C(N)=O)c3)ccc12)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.45
CCNE2 O96020 1/20 0.45
CCNE1 P24864 1/20 0.45
ERN1 O75460 3/20 0.42
CCNT1 O60563 1/20 0.41
CCND1 P24385 1/20 0.41
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
CDK7 P50613 1/20 0.41
CDK9 P50750 1/20 0.41
CCNH P51946 1/20 0.41
MNAT1 P51948 1/20 0.41
CDK6 Q00534 1/20 0.41
PDK2 Q15119 1/20 0.39
SYK P43405 2/20 0.39
DHFR P00374 1/20 0.38
LIMK1 P53667 3/20 0.38
MAPK14 Q16539 1/20 0.38
ALOX5AP P20292 1/20 0.37
LIMK2 P53671 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL436516 1.00 CDK2 (0.45) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL435776 1.00 CDK2 (0.45) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL435291 0.78 CDK2 (0.43) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL437501 0.78 CDK2 (0.43) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL3955501 0.76 MAPK14 (0.54) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL436517 0.75 PDK2 (0.43) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL397374 0.69 MAPK14 (0.67) MAPK14KDRMAPK13LCKCSF1R
SCHEMBL394468 0.69 MAPK14 (0.67) MAPK14KDRMAPK13LCKCSF1R
SCHEMBL396414 0.69 MAPK14 (0.67) MAPK14KDRMAPK13LCKCSF1R
SCHEMBL4516742 0.69 DHODH (0.59) CDK2CCNE2CCNE1ERN1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101612-B2 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes AMGEN INC. (US) 2012-01-24 US disclosed